DigiNepal Health ENनेहि

← स्वास्थ्य · दवाएँ

💊 Daunorubicin

💊 यह केवल जानकारी है, प्रिस्क्रिप्शन नहीं। कोई भी दवा लेने से पहले डॉक्टर या फार्मासिस्ट से सलाह लें। ओवरडोज़/विषाक्तता पर 102 पर कॉल करें।

Common side effects

Other reactions include: Cutaneous Reversible alopecia occurs in most patients. Rash, contact dermatitis and urticaria have occurred rarely. Gastrointestinal Acute nausea and vomiting occur but are usually mild. Antiemetic therapy may be of some help. Mucositis may occur 3 to 7 days after administration. Pregnancy (label summary): Daunorubicin hydrochloride may cause fetal harm when administered to a pregnant woman. Decreases in fetal birth weight and post-delivery growth rate were observed in mice. There are no adequate and well-controlled studies in pregnant women. Breastfeeding (label summary): Nursing Mothers It is not known whether this drug is excreted in human milk. General information only, not medical advice and not a prescription. No doses are given. Always consult a doctor or pharmacist before starting, stopping or changing any medicine, especially in pregnancy, breastfeeding, children, older age or with other medicines.

🚨 ओवरडोज़ या विषाक्तता

ओवरडोज़/विषाक्तता की आशंका पर अभी 102 पर कॉल करें।

📞 102

स्रोत: FDA SPL label (openFDA/DailyMed); RxNorm (NLM) · Reference · Reference · Reference

US FDA DailyMed; NLM RxNorm

आपात — कॉल📞 102